We appreciate the sensitivities of Rescigno et al. [1] in their letter questioning the justification for animal experiments, suggesting a careful and selective approach in choosing a canine model in science. In their comment, Rescigno et al. referred to the use of dogs, which was described in our study [2]. They assert that we should not have used dogs, because we were not studying a totally new device but a modification of an existing device, and they allege that our studies could have been done in cadavers or cell cultures. We respectfully disagree.

Prior to establishing this study protocol, the study investigators and study consultants carefully considered potential alternatives to animal use (e.g. in silico, in vitro and in cadavers). It has been determined [and the University of Minnesota’s Institutional Animal Care and Use Committee (IACUC) concurred] that animals (in this case, dogs) were necessary to achieve the study’s specific objectives to (i) evaluate safety because the device approach/deployment differed with the new device design and new fabric; (ii) explore system performance (implantability scores) in a beating heart with normal blood volumes in the heart chambers (impossible with cadavers); complete appendage occlusion without device migration over time had to be evaluated in live animals; and (iii) assess biocompatibility and possible complications, also in live animals; cell cultures could not yield such assessments.

Canines were used because their cardiac size and anatomy resemble those of humans; the dog’s left atrial appendage is human-like in morphology, size and tissue thickness, making the canine model optimal for evaluating occlusion efficacy. Atrial appendage exclusion and atrial fibrillation have been widely studied in canine models, with results published in medical journals [3–6]. One of our greatest concerns with the new clip was the possibility of occluding the circumflex artery. That artery is also similar in dogs and humans, making dogs an ideal test subject. In sheep, the circumflex is in a different location. In pigs, it is at a different site, and the appendage is significantly different from that of humans. We believe that our animal selection was necessary and appropriate, as approved by the IACUC. As cardiovascular investigators, we acknowledge that in vivo studies using research animals must inevitably take place if medicine is to progress.

REFERENCES

[1]

Rescigno
G
,
Hogan
J
,
Strong
P.
The ideal use of dogs in medicine
.
Eur J Cardiothorac Surg
2018
;
54
:197.

[2]

Sunagawa
G
,
Karimov
JH
,
Breitbach
M
,
Robinson
NA
,
Fukamachi
K.
Impact of a refined advanced design for left atrial appendage exclusion
.
Eur J Cardiothorac Surg
2017
;
52
:
1098
103
.

[3]

Lee
RJ
,
Bartus
K
,
Yakubov
SJ.
Catheter-based left atrial appendage (LAA) ligation for the prevention of embolic events arising from the LAA: initial experience in a canine model
.
Circ Cardiovasc Interv
2010
;
3
:
224
9
.

[4]

Kimura
T
,
Takatsuki
S
,
Miyoshi
S
,
Katsumata
Y
,
Nishiyama
T
,
Nishiyama
N
et al.
Pericardial endoscopy-guided left atrial appendage ligation: a pilot study in a canine model
.
Circ Cardiovasc Interv
2014
;
7
:
844
50
.

[5]

Panikker
S
,
Virmani
R
,
Sakakura
K
,
Kolodgie
F
,
Francis
DP
,
Markides
V
et al.
Left atrial appendage electrical isolation and concomitant device occlusion: a safety and feasibility study with histologic characterization
.
Heart Rhythm
2015
;
12
:
202
10
.

[6]

Dai
M
,
Bao
M
,
Zhang
Y
,
Yu
L
,
Cao
Q
,
Tang
Y
et al.
Low-level carotid baroreflex stimulation suppresses atrial fibrillation by inhibiting left stellate ganglion activity in an acute canine model
.
Heart Rhythm
2016
;
13
:
2203
12
.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/journals/pages/about_us/legal/notices)